Global Non Alcoholic Steatohepatitis Market Analysis


  • Type: Common Disease Area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 237

  • Format: PPT, PDF

Global Non-Alcoholic Steatohepatitis (NASH) Market: Segmented by Drug Type (Vitamin E & Pioglitazone, Ocaliva, Elafibranor, and Selonsertib & Cenicriviroc), and Sales Channel (Hospital Pharmacy, Online Provider, and Retail Pharmacy) – Global Opportunity Analysis and Industry Forecast, 2019-2028


Report Overview

The global Non-Alcoholic Steatohepatitis (NASH) drugs market size stood at around USD 2.94 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

The factors such as rising healthcare expenditure, increasing pharmaceutical R&D expenditure, surging diabetic population, escalating obese population, unmet medical needs and sedentary lifestyles are expected to drive the growth of the market. However, the market growth would be challenged by the lethargic drug approval process, high treatment cost and less definitive diagnostic methods for NASH/NAFLD

Market Drivers

Incidence of chronic liver diseases is expected to propel the demand for NASH biomarkers over the forecast period. The National Health and Nutrition Examination Survey recently found that approximately 30% of Nonalcoholic Fatty Liver Diseases (NAFLD) occurred in the U.S. alone. This disease remains undiagnosed, as a liver can remain fatty without any change in its function. However, it can progress into a serious condition, known as nonalcoholic steatosis that may result in liver failure. NASH is characterized by inflammation and irreversible cell death

Rising demand for non-invasive diagnostic tools for detection of NASH is another driver of market. Traditionally, liver biopsy is performed to diagnose NAFLD and its degenerative condition, that is, NASH. This technique is expensive and invasive in nature. This disadvantage has led to the development of noninvasive and cost-efficient diagnostic techniques such as biomarker tests. It is observed that many key companies spent significantly on research and development activities to introduce novel biomarker tests. These factors are expected to propel NASH biomarkers market in the coming years

1. Global Non-Alcoholic Steatohepatitis Drugs Market……
A. Market Size
2. Market Growth Drivers…………………………………
A. Rising HealthCare Expenditure
B. Increase in Pharmaceutical R&D Expenditures
C. Surging Diabetic Population
D. Escalating Obese Population
3. Market Dynamics………………………………………………
A. Surging Market Penetration for Major NASH Drugs
B. Increasing Prevalence of NASH
C. Progressing NASH Diagnosis Methods and Biomarkers
D. Growth in E-Commerce Pharmaceutical Products Sales
4. Dermatological Therapeutics Market Segmentation…
A. Drug Class
I. Vitamin E & pioglitazone
II. Obeticholic acid
III. Elafibranor
IV. Selonsertib & cenicriviroc
B. Geography
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. Middle-East and Africa Market Analysis
V. South America Market Analysis
5. Non-Alcoholic Steatohepatitis Major Drugs Market Share
A. Market Analysis, Insights and Forecast – By Drug Type
6. Competitive Landscape…………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles……………………………………………
A. Allergan Plc Company overview, Product & Services, Strategies & Financials
B. Cadila Healthcare Company overview, Product & Services, Strategies & Financials
C. Conatus Pharmaceuticals Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………
A. New Trends and Recent Developments
B. Future Opportunities
10. Conclusion

Market Segmentation

By Sales Channel:

According to sales channel, the global non-alcoholic steatohepatitis (NASH) market is categorized into hospital pharmacy, online provider, and retail pharmacy. At present, the retail pharmacy segment is the major revenue contributor, and is estimated to remain dominant during the forecast period due to the strong presence of drug stores & retail pharmacies around the world. On the other side, the online provider segment is anticipated to exhibit the fastest market growth due to rise in awareness of online pharmacies and increase in preference for online purchase over the traditional methods

By Region:

North America’s non-alcoholic steatohepatitis (NASH) market is estimated to showcase a healthy CAGR over the analysis period. As per recent statistics, the incidence rate of NAFLD in the US is around 25%, out of which non-alcoholic steatohepatitis (NASH) accounts for 3-8%. The growing prevalence of diseases in the region is creating favorable growth opportunities for drugmakers. Key regional manufacturers in the industry are investing in R&D activities to boost the development of novel drugs for non-alcoholic steatohepatitis (NASH) treatment


Competitive Landscape

Several key manufacturers, including Genfit, Gilead Sciences, and others, are focusing on bringing forth effective non-alcoholic steatohepatitis (NASH) treatment. For instance, the Food & Drug Administration has accepted a new drug application by Intercept Pharmaceuticals for the treatment of liver fibrosis caused by non-alcoholic steatohepatitis (NASH). Intercept also announced that obeticholic acid (OCA), under the Ocaliva brand, has already been approved for the treatment of primary biliary cholangitis/ cirrhosis (an autoimmune liver disease) and has a PDUFA (Prescription Drug User Fee Act) date. The company claimed that if OCA is approved, it would be the first therapy available for the treatment of fibrosis due to non-alcoholic steatohepatitis, a condition that is estimated to become one of the major causes of liver transplant in the United States


Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements